National Health Service (NHS) trusts in England reported a £791 million ($1 billion) deficit last year, despite receiving an additional £1.8 billion from government through a reform program.
In acute care, most NHS trusts - the bodies responsible for delivering healthcare in hospitals and other parts of the system - are also forecasting a deficit for the current financial year.
Meanwhile Clinical Commissioning Groups (CCGs), the primary care providers that control around two-thirds of the NHS budget, expect to deliver a quarter billion pound surplus for the previous year, after a requirement to keep 1% of their budgets in reserve was dropped.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze